AIM: To determine the presence of Helicobacter species DNA in the liver of chronic hepatitis C (CHC) patients with and without cirrhosis as compared to controls, and to identify the bacterial species involved. METHODS: Seventy-nine consecutive patients (HBV and HIV negative) with a liver sample obtained after liver biopsy or hepatic resection were studied: 41 with CHC without cirrhosis, 12 with CHC and cirrhosis, and 26 controls (HCV negative). Polymerase chain reactions (PCRs) targeting Helicobacter 16S rDNA and species-specific were performed on DNA extracted from the liver. A gastric infection with H pylori was determined by serology and confirmed by 13C-urea breath test. RESULTS: Overall, Helicobacter 16S rDNA was found in 16 patients (20.2%). Although positive cases tended to be higher in CHC patients with cirrhosis (41.6%) than in those without cirrhosis (17.0%) or in controls (15.4%), the difference was not statistically significant (P = 0.08). H pylori-like DNA was identified in 12 cases and H. pullorum DNA in 2, while 2 cases remained unidentified. Gastric infection with H pylori was found in only 2 of these patients. CONCLUSION: Our results do not confirm the association of Helicobacter species DNA in the liver of CHC patients with advanced liver disease. The lack of correlation between positive H pylori serology and the presence of H pylori-like DNA in the liver may indicate the presence of a variant of this species.
AIM: To determine the presence of Helicobacter species DNA in the liver of chronic hepatitis C (CHC) patients with and without cirrhosis as compared to controls, and to identify the bacterial species involved. METHODS: Seventy-nine consecutive patients (HBV and HIV negative) with a liver sample obtained after liver biopsy or hepatic resection were studied: 41 with CHC without cirrhosis, 12 with CHC and cirrhosis, and 26 controls (HCV negative). Polymerase chain reactions (PCRs) targeting Helicobacter 16S rDNA and species-specific were performed on DNA extracted from the liver. A gastric infection with H pylori was determined by serology and confirmed by 13C-urea breath test. RESULTS: Overall, Helicobacter 16S rDNA was found in 16 patients (20.2%). Although positive cases tended to be higher in CHCpatients with cirrhosis (41.6%) than in those without cirrhosis (17.0%) or in controls (15.4%), the difference was not statistically significant (P = 0.08). H pylori-like DNA was identified in 12 cases and H. pullorum DNA in 2, while 2 cases remained unidentified. Gastric infection with H pylori was found in only 2 of these patients. CONCLUSION: Our results do not confirm the association of Helicobacter species DNA in the liver of CHCpatients with advanced liver disease. The lack of correlation between positive H pylori serology and the presence of H pylori-like DNA in the liver may indicate the presence of a variant of this species.
Authors: Cornelis Verhoef; Raymond G Pot; Rob A de Man; Pieter E Zondervan; Ernst J Kuipers; Jan N IJzermans; Johannes G Kusters Journal: Eur J Gastroenterol Hepatol Date: 2003-11 Impact factor: 2.566
Authors: J M Ward; J G Fox; M R Anver; D C Haines; C V George; M J Collins; P L Gorelick; K Nagashima; M A Gonda; R V Gilden Journal: J Natl Cancer Inst Date: 1994-08-17 Impact factor: 13.506
Authors: Jenni K Boonjakuakul; Michael Syvanen; Arun Suryaprasad; Christopher L Bowlus; Jay V Solnick Journal: J Infect Dis Date: 2004-07-30 Impact factor: 5.226
Authors: Michelle L Turk; Laura D Cacioppo; Zhongming Ge; Zeli Shen; Mark T Whary; Nicola Parry; Samuel R Boutin; Hilton J Klein; James G Fox Journal: J Med Microbiol Date: 2012-02-02 Impact factor: 2.472
Authors: Paola Pisani; Mark T Whary; Ingrid Nilsson; Supannee Sriamporn; Torkel Wadström; James G Fox; Asa Ljungh; David Forman Journal: Clin Vaccine Immunol Date: 2008-07-02
Authors: Alexis García; Yan Feng; Nicola M A Parry; Amanda McCabe; Melissa W Mobley; Kvin Lertpiriyapong; Mark T Whary; James G Fox Journal: Gut Microbes Date: 2013-08-07
Authors: Laura D Cacioppo; Michelle L Turk; Zeli Shen; Zhongming Ge; Nicola Parry; Mark T Whary; Samuel R Boutin; Hilton J Klein; James G Fox Journal: J Med Microbiol Date: 2012-05-11 Impact factor: 2.472